KUSH PARMAR, Director at Q32 Bio, holds 181.44K shares in Q32 Bio (Ticker: QTTB), holds ― shares in Audentes Therapeutics (Ticker: ~BOLD), holds ― shares in scPharmaceuticals (Ticker: SCPH). Most recently, KUSH PARMAR Sold ― shares of Q32 Bio on Dec 28, 2020 for an estimated value of 6.41M.
KUSH PARMAR latest transaction was an Informative Sell of $6.41M.
What was KUSH PARMAR's most profitable transaction?
KUSH PARMAR’s most profitable transaction was an Informative Sell of VOR stock on November 18, 2021. The return on the trade was 69.50%.
What is KUSH PARMAR's role in Q32 Bio?
KUSH PARMAR's role in Q32 Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.